AstraZeneca Annual Report and Form 20-F Information 2011

Our year in brief

Summary financial and operational information for 2011

  • Sales

    $m (-2%)
          

    1.2_chart_bar_185x120_sales.png
  • Core operating profit

    $m (-4%)
           

    1.2_chart_bar_185x120_core-operating-profit.png
  • Reported operating profit

    $m (+10%)
              

    1.2_chart_bar_185x120_reported-operating-profit.png
  • Net cash flow from operating activities

    $m

    1.2_chart_bar_185x120_net-cash-flow-from-operating-activities.png
  • Core gross margin

    $m (unchanged)
           

    1.2_chart_bar_185x120_core-gross-margin.png
  • Reported gross margin

    $m (unchanged)
            

    1.2_chart_bar_185x120_reported-gross-margin.png
  • Core earnings per Ordinary Share

    $m (+7%)
              

    1.2_chart_bar_185x120_core-earnings-per-ordinary-share.png
  • Reported basic earnings per Ordinary Share

    $m (+29%)

    1.2_chart_bar_185x120_reported-basic-earnings-per-ordinary-share.png
null null null null null null null null null null null null null null null null null null